1. 53: A Retrospective Study of Low-Risk, Node-Positive Patients Eligible for the Canadian Cancer Trial Group MA.39 (TAILOR RT) Randomized Trial of Regional Nodal Radiotherapy. (October 2021) Authors: Sit, Daegan; Lalani, Nafisha; Chan, Elisa; Tran, Eric; Speers, Caroline; Gondara, Lovedeep; Lohrisch, Caroline; Gelmon, Karen; Nichol, Alan Journal: Radiotherapy and oncology Issue: Volume 163(2021)Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 7: Rates of Regional Radiotherapy Receipt Over Time in Low-Risk, Node Positive Breast Cancer. (September 2022) Authors: Sit, Daegan; Lalani, Nafisha; Chan, Elisa; Tran, Eric; Speers, Caroline; Gondara, Lovedeep; Chia, Stephen; Gelmon, Karen; Lohrisch, Caroline; Nichol, Alan Journal: Radiotherapy and oncology Issue: Volume 174(2022)Supplement 1 Page Start: S6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2‐Positive Metastatic Breast Cancer (CCTG IND.229). (16th August 2019) Authors: Chia, Stephen; Bedard, Phillipe L.; Hilton, John; Amir, Eitan; Gelmon, Karen; Goodwin, Rachel; Villa, Diego; Cabanero, Michael; Tu, Dongsheng; Tsao, Ming; Seymour, Lesley Journal: Oncologist Issue: Volume 24:Number 11(2019) Page Start: 1439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis. (July 2021) Authors: Gelmon, Karen A.; Fasching, Peter A.; Couch, Fergus J.; Balmaña, Judith; Delaloge, Suzette; Labidi-Galy, Intidhar; Bennett, James; McCutcheon, Susan; Walker, Graham; O'Shaughnessy, Joyce; Timcheva, Constanta; Tomova, Antoaneta; Eisen, Andrea; Gelmon, Karen; Lemieux, Julie; Bazan, Fernando; Bourge... Journal: European journal of cancer Issue: Volume 152(2021) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Communication Challenges for Chronic Metastatic Cancer in an Era of Novel Therapeutics. (July 2013) Authors: Thorne, Sally E.; Oliffe, John L.; Oglov, Valerie; Gelmon, Karen Journal: Qualitative health research Issue: Volume 23:Number 7(2013) Page Start: 863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density. (December 2014) Authors: Pataky, Reka; Ismail, Zahra; Coldman, Andrew J; Elwood, Mark; Gelmon, Karen; Hedden, Lindsay; Hislop, Greg; Kan, Lisa; McCoy, Bonnie; Olivotto, Ivo A; Peacock, Stuart Journal: Journal of medical screening Issue: Volume 21:Number 4(2014) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Do anthracyclines still have a role in adjuvant chemotherapy of breast cancer?. (January 2011) Authors: Davidson, Ashley; Gelmon, Karen Journal: Future oncology Issue: Volume 7:Number 1(2011) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effects of exercise dose and type during breast cancer chemotherapy on longer‐term patient‐reported outcomes and health‐related fitness: A randomized controlled trial. Issue 1 (27th June 2019) Authors: An, Ki‐Yong; Morielli, Andria R.; Kang, Dong‐Woo; Friedenreich, Christine M.; McKenzie, Donald C.; Gelmon, Karen; Mackey, John R.; Reid, Robert D.; Courneya, Kerry S. Journal: International journal of cancer Issue: Volume 146:Issue 1(2020) Page Start: 150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2. (October 2021) Authors: Gelmon, Karen; Walshe, Janice M.; Mahtani, Reshma; Joy, Anil A.; Karuturi, Meghan; Neven, Patrick; Lu, Dongrui Ray; Kim, Sindy; Schnell, Patrick; Bananis, Eustratios; Schwartzberg, Lee Journal: Breast Issue: Volume 59(2021) Page Start: 321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). (October 2017) Authors: Paluch-Shimon, Shani; Pagani, Olivia; Partridge, Ann H.; Abulkhair, Omalkhair; Cardoso, Maria-João; Dent, Rebecca Alexandra; Gelmon, Karen; Gentilini, Oreste; Harbeck, Nadia; Margulies, Anita; Meirow, Dror; Pruneri, Giancarlo; Senkus, Elzbieta; Spanic, Tanja; Sutliff, Medha; Travado, Luzia; Pecca... Journal: Breast Issue: Volume 35(2017) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗